Trial Profile
Trimetazidine modified release tablets in Angina and Poor muscle function (TAP):a randomized controlled study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 01 Mar 2018
Price :
$35
*
At a glance
- Drugs Trimetazidine (Primary)
- Indications Angina pectoris
- Focus Therapeutic Use
- 01 Mar 2018 New trial record